Riding the wave crest ASX stocks at 52 W high
With strengthening investor optimism, these ASX-listed companies are hovering near their 52-week highs powered by robust earnings, solid balance sheets and promising growth.
EcoGraf Limited (ASX: EGR)
is building a fully integrated graphite business starting from its Epanko Graphite Project in Tanzania to its own HFfree purification process that removes the use of harmful hydrofluoric acid in battery anode making process.
UBS has predicted that natural graphite demand could rise almost six times by 2030 and EcoGraf seems to be in a strong spot to gain from the rising global shift towards non chinese sources.
EcoGraf looks quite stable with around $11.2 million in cash and It is also moving forward on getting a US$105 million debt funding from Germany’s KfW IPEX-Bank for the Epanko project. The project numbers look solid at 25,000 tonnes per annum plant with a pre tax NPV of about US$282 million and IRR of 42%.
With both EU and US listing graphite as a key mineral, EcoGraf’s clean and expandable technology gives it a strong edge.
BlinkLab Limited (ASX: BB1)
has released excellent results from its US pilot study for its smartphone based diagnostic device called BlinkLab Dx1 which is used for autism testing.
The study covered around 485 kids and reached 83.7% sensitivity and 84.7% specificity, which is much higher than FDA’s set target of 65%. This is a big milestone for the Princeton based biotech company as it proves that its AI powered 15 minute test can detect autism and ADHD just by reading facial and behavior patterns.
For FY25, BlinkLab posted a revenue of about $375,551 which is up almost 916% compared to last year. The company had around $8.7 million cash in hand by 30 June 2025.
With partnerships in top US hospitals like Cincinnati Children’s Hospital, Seattle Children’s Hospital and University of Pennsylvania, BlinkLab looks set to lead the way in affordable AI based mental health testing. It is aiming for a huge global market worth over US$15 billion in autism and neurodevelopmental diagnostics.
Praemium Limited (ASX: PPS)
posted another strong quarter of fund inflows and platform growth.
For the September 2025 quarter, total funds under administration (FUA) went up 13% to about $67 billion. Platform FUA rose 10% to $32 billion supported by net inflows of $667 million.
The integration of OneVue platform is moving as planned and the company is also working on its own superannuation system with more AI based automation features.
With organic growth picking up speed, more advisers joining and a healthy sales pipeline, Praemium looks in a strong position to keep growing and deliver steady earnings into FY26.
(Source: Company Announcements)
Get Your Free Report on Top 5 ASX Stocks on WhatsApp
Instant Access. No Credit Card Required.
Receive on WhatsApp
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialASX Stock Research & Recommendations — 7‑day free trial
Independent, analyst‑driven insights.
- Stock of the week report
- Daily Analysis Report
- No credit card required
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Article
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
